Skip to main content
. 2020 Sep 6;2020(9):CD010458. doi: 10.1002/14651858.CD010458.pub3

2. Maximum methaemoglobin percentages reported in each trial with tafenoquine 300 mg single dose and standard‐dose primaquine.

Trial Drug Maximum methaemoglobin percentage
Lacerda 2019 TQ
PQ
13%
14.7%
Llanos‐Cuentas 2014 TQ Not reported for TQ 300 mg group
Llanos‐Cuentas 2019 TQ
PQ
1.9%
4.1%

PQ: primaquine; TQ: tafenoquine.